Pharmaceutical giant Merck & Co. Inc. will close two of its New Jersey sites in 2010, with a third to be phased out by 2012, according to spokeswoman Amy Rose.
Following its 2009 merger with Kenilworth-based Schering-Plough Corp., “Merck has had efforts under way to evaluate our facilities needs worldwide,” Rose said in an e-mail message.
The company, based in the Whitehouse Station section of Readington, will shutter its Roseland and Lafayette sites in 2010, and will phase out its Union facility by the end of 2012, Rose said.
“Some employees will be separated as part of the New Jersey consolidation, but a significant number will relocate to sites with existing research and development and manufacturing operations or available office space,” she added. “Merck will continue to have a strong commitment to New Jersey, with about 12,000 employees and important facilities, including Rahway, Kenilworth, Summit and Whitehouse Station.”
E-mail Martin C. Daks at email@example.com